CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $100,000 | +212.5% | 36,239 | +73.4% | 0.00% | +33.3% |
| Q3 2020 | $32,000 | -25.6% | 20,900 | -8.7% | 0.00% | -25.0% |
| Q2 2020 | $43,000 | +10.3% | 22,900 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $39,000 | -66.9% | 22,900 | -43.7% | 0.01% | -50.0% |
| Q4 2019 | $118,000 | +202.6% | 40,700 | -33.7% | 0.01% | +150.0% |
| Q3 2019 | $39,000 | -33.9% | 61,400 | +0.7% | 0.00% | -33.3% |
| Q2 2019 | $59,000 | -30.6% | 61,000 | -0.8% | 0.01% | -33.3% |
| Q1 2019 | $85,000 | +25.0% | 61,500 | -2.8% | 0.01% | 0.0% |
| Q4 2018 | $68,000 | -85.4% | 63,300 | -16.2% | 0.01% | -83.0% |
| Q3 2018 | $465,000 | +36.0% | 75,550 | +54.8% | 0.05% | +26.2% |
| Q4 2017 | $342,000 | +33.6% | 48,812 | +66.5% | 0.04% | +27.3% |
| Q3 2017 | $256,000 | – | 29,312 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |